Methods of using 4-(amino)-2-(2,6-dioxo(3-piperidly))-isoindoline-3-dione for the treatment of myelodysplastic syndromes

作者: Jerome B. Zeldis

DOI:

关键词:

摘要: Methods of treating, preventing and/or managing myelodysplastic syndromes are disclosed. Specific methods encompass the administration an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, prodrug thereof, alone in combination with second active ingredient, transplantation blood cells. ingredients capable affecting cell production. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use invention also

参考文章(132)
B E Robinson, I A Tabbara, Hematopoietic growth factors. Anticancer Research. ,vol. 11, pp. 81- 90 ,(1991)
MA Vadas, G Varigos, N Nicola, S Pincus, A Dessein, D Metcalf, FL Battye, Eosinophil activation by colony-stimulating factor in man: metabolic effects and analysis by flow cytometry. Blood. ,vol. 61, pp. 1232- 1241 ,(1983) , 10.1182/BLOOD.V61.6.1232.1232
Peter Greenberg, Christopher Cox, Michelle M. LeBeau, Pierre Fenaux, Pierre Morel, Guillermo Sanz, Miguel Sanz, Teresa Vallespi, Terry Hamblin, David Oscier, Kazuma Ohyashiki, Keisuke Toyama, Carlo Aul, Ghulam Mufti, John Bennett, International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes Blood. ,vol. 89, pp. 2079- 2088 ,(1997) , 10.1182/BLOOD.V89.6.2079
R H Weisbart, J C Gasson, D W Golde, Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. Journal of Immunology. ,vol. 137, pp. 3584- 3587 ,(1986)
Loretta L. Nielsen, Joseph J. Catino, Viyyoor M. Girijavallabhan, Walter R. Bishop, Paul Kirschimeier, Ashit Ganguly, Ronald J. Doll, David L. Cutler, Ming Liu, Method for treating proliferative diseases ,(1998)